Boardroom Alpha
Boardroom Alpha
HR · Current Report (Form 8-K) · Filed May 20, 2026

Healthcare Realty Trust Inc — Current Report (Form 8-K)

Form
8-K
Filed
May 20, 2026
Period
May 20, 2026
Ticker
HR
Accession
0001360604-26-000051
Boardroom Alpha · Filing insights

Stockholders re-elected directors, ratified Deloitte & Touche LLP as auditor, and approved executive compensation (non-binding).

About Healthcare Realty Trust Inc
Market cap
$6.8B
1Y TSR
+41.5%
3Y TSR
+9.0%
Board grade
B-
Sector
Real Estate
CEO
Peter A Scott
Last annual meeting: May 19, 2026 · View full Healthcare Realty Trust Inc profile →
hr-20260520

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 20, 2026 (May 19, 2026)
Healthcare Realty Trust Incorporated
(Exact name of registrant as specified in its charter)
Maryland001-3556820-4738467
(State or other jurisdiction of incorporation or organization)(Commission File Number)(I.R.S. Employer Identification No.)
3310 West End Avenue, Suite 700Nashville,Tennessee37203
(615)
269-8175
(Address of Principal Executive Office and Zip Code)
(Registrant’s telephone number, including area code)

(Former name or former address, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading symbol(s)Name of each exchange on which registered
Class A Common Stock, $0.01 par value per shareHRNew York Stock Exchange
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
  
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
  
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
  
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter):
Healthcare Realty Trust IncorporatedEmerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Healthcare Realty Trust Incorporated





Item 5.07Submission of Matters to a Vote of Security Holders.
The Company held its annual meeting of stockholders on May 19, 2026. At the annual meeting, there were present in person or by proxy 326,851,561 shares of the Company’s common stock, representing approximately 94.32% of the total outstanding shares. The proposals considered at the annual meeting were voted on as follows:
1) The following individuals were elected to serve as directors for one-year terms or until their successors have been elected and take office.
NomineeVotes ForVotes AgainstAbstentionsBroker Non-Votes
Percent Voting For 1
Thomas N. Bohjalian310,012,0874,320,865209,31512,309,29498.62%
David B. Henry307,229,3017,155,998156,96812,309,29497.72%
Constance B. Moore283,872,96629,432,3121,236,98912,309,29490.60%
Glenn Rufrano295,613,65218,769,748158,86712,309,29494.02%
Peter A. Scott310,990,0473,395,714156,50612,309,29498.91%
Donald C. Wood295,697,90918,691,723152,63512,309,29494.05%
1 Total “For” votes as a percentage of the shares voted on the proposal.

2) The stockholders ratified the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026, by the following vote:
Votes Cast in FavorVotes Cast AgainstAbstentionsBroker Non-Votes
Percent Voting For 1
326,270,871438,695141,99599.86%
1 Total "For" votes as a percentage of the shares voted on the proposal.

3) The stockholders approved, on a non-binding advisory basis, the Company’s compensation of its executive officers by the following vote:
Votes Cast in FavorVotes Cast AgainstAbstentionsBroker Non-Votes
Percent Voting For 1
288,148,64126,120,602273,02412,309,29491.68%
1 Total “For” votes as a percentage of the shares voted on the proposal.



SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: May 20, 2026Healthcare Realty Trust Incorporated  
By:/s/ Daniel Gabbay   
  Name: Daniel Gabbay 
  Title: Executive Vice President and Chief Financial Officer 



From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Healthcare Realty Trust Inc (HR)

Reference

Frequently asked questions

When did Healthcare Realty Trust Inc file this 8-K?
Healthcare Realty Trust Inc (HR) filed this Current Report (Form 8-K) with the SEC on May 20, 2026. The accession number assigned by EDGAR is 0001360604-26-000051.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
Stockholders re-elected directors, ratified Deloitte & Touche LLP as auditor, and approved executive compensation (non-binding). This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find Healthcare Realty Trust Inc's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K Healthcare Realty Trust Inc has filed under CIK 1360604, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer